Infrared spectrometric biomarkers for ulcerative colitis screening using human serum samples.
Hemendra Ghimire1, Emilie Viennois2, Xinjie Hu3
1Department of Physics and Astronomy, Georgia State University, Atlanta, GA, USA.
Infrared spectrometry detected unique spectral signatures in serum, offering a potential new diagnostic test for ulcerative colitis (UC). This method shows high sensitivity and specificity for identifying molecular changes associated with the disease.
Area of Science:
- Biomedical Spectroscopy
- Molecular Diagnostics
- Gastroenterology
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
- Accurate and early diagnosis of UC is crucial for effective management.
- Current diagnostic methods can be invasive or lack specificity.
Purpose of the Study:
- To investigate the potential of infrared (IR) spectrometry for diagnosing colitis.
- To identify specific spectral signatures in serum indicative of colitis.
- To evaluate the diagnostic performance of identified spectral signatures.
Main Methods:
- Serum samples from 18 UC patients and 28 healthy volunteers were analyzed using IR spectrometry.
- Analysis focused on absorbance values and ratios at specific wavenumbers (e.g., 1033, 1076, 1121, 1020 cm⁻¹).
- Protein secondary structure was assessed via deconvolution of the amide I band.
Main Results:
- Statistically significant differences were observed in five spectral signatures between UC patients and healthy controls.
- The spectral signature I₁₁₂₁/I₁₀₂₀ demonstrated 100% sensitivity and 86% specificity.
- Colitis-induced molecular alterations correlated with specific vibrational mode fluctuations.
Conclusions:
- IR spectrometry can detect molecular changes in serum associated with colitis.
- Specific spectral signatures show promise as a non-invasive diagnostic biomarker for UC.
- Findings support the development of IR-based diagnostics for human patients, consistent with prior animal model studies.
More Related Videos
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Related Concept Videos
Serum Laboratory Studies, Stool Test, Breath Test
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Applications of IR Spectroscopy: Overview
Infrared (IR) Spectroscopy: Overview
Different compounds display unique properties due to their...
